2-(nitrooxy)ethyl apovincaminate has been researched along with 8-bromocyclic gmp in 1 studies
| Studies (2-(nitrooxy)ethyl apovincaminate) | Trials (2-(nitrooxy)ethyl apovincaminate) | Recent Studies (post-2010) (2-(nitrooxy)ethyl apovincaminate) | Studies (8-bromocyclic gmp) | Trials (8-bromocyclic gmp) | Recent Studies (post-2010) (8-bromocyclic gmp) |
|---|---|---|---|---|---|
| 20 | 1 | 1 | 1,516 | 2 | 93 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, N; Muramatsu, M; Okuyama, S; Otomo, S; Tanaka, M; Tsuchida, K; Yamaura, H | 1 |
1 other study(ies) available for 2-(nitrooxy)ethyl apovincaminate and 8-bromocyclic gmp
| Article | Year |
|---|---|
Effects of VA-045, a novel apovincaminic acid derivative, on isolated blood vessels: cerebroarterial selectivity.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Aorta; Basilar Artery; Blood Vessels; Cerebral Arteries; Coronary Vessels; Cyclic GMP; Dogs; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium Chloride; Rats; Rats, Wistar; Sensitivity and Specificity; Vasodilator Agents; Vinca Alkaloids | 1993 |